(Q47726415)

5 February 2018

review article

1 reference

title

LDL oxidation: therapeutic perspectives. (English)

1 reference

5 February 2018

author name string

Heller FR

series ordinal

1

1 reference

5 February 2018

Descamps O

series ordinal

2

1 reference

5 February 2018

Hondekijn JC

series ordinal

3

1 reference

5 February 2018

publication date

1 April 1998

1 reference

5 February 2018

published in

Atherosclerosis

1 reference

5 February 2018

volume

137 Suppl

1 reference

5 February 2018

page(s)

S25-31

1 reference

5 February 2018

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Oxidative status of lipoproteins in coronary disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

The influence of antioxidant nutrients on platelet function in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

On the mechanism of the anticlotting action of vitamin E quinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Wine, alcohol, platelets, and the French paradox for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Garlic supplementation and lipoprotein oxidation susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Does diet or alcohol explain the French paradox?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Low density lipoprotein composition and oxidizability in coronary disease--apparent favourable effect of beta blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effects of ACE inhibitors on oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Antioxidant Protection of LDL by Physiological Concentrations of 17β-Estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900308-0

10.1016/S0021-9150(97)00308-0

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

release_nlekcqyg7rhenpo2v43ndjpmim

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nlekcqyg7rhenpo2v43ndjpmim

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9694538

1 reference

5 February 2018